Tenet Healthcare (NYSE:THC) Given New $270.00 Price Target at Truist Financial

Tenet Healthcare (NYSE:THC) had its price target upped by Truist Financial from $240.00 to $270.00 in a research report sent to investors on Tuesday morning, MarketBeat reports. The firm currently has a buy rating on the stock.

Other research analysts have also issued reports about the stock. Cantor Fitzgerald lifted their price target on shares of Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a report on Wednesday, October 29th. Guggenheim lifted their target price on Tenet Healthcare from $257.00 to $271.00 and gave the company a “buy” rating in a research note on Friday. Morgan Stanley reiterated an “overweight” rating and set a $260.00 price target on shares of Tenet Healthcare in a research report on Thursday, February 12th. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. Finally, Raymond James Financial set a $245.00 target price on Tenet Healthcare in a research report on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $246.71.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $234.37 on Tuesday. The firm has a market cap of $20.60 billion, a PE ratio of 15.13, a price-to-earnings-growth ratio of 0.96 and a beta of 1.44. Tenet Healthcare has a 1 year low of $109.82 and a 1 year high of $235.77. The firm’s 50-day simple moving average is $199.97 and its 200-day simple moving average is $196.22. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.08 by $0.62. The business had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business’s revenue was up 8.9% compared to the same quarter last year. During the same period in the prior year, the company posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts forecast that Tenet Healthcare will post 12.24 earnings per share for the current fiscal year.

Insider Activity

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.81% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its stake in Tenet Healthcare by 1.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock valued at $1,488,484,000 after purchasing an additional 119,809 shares during the last quarter. Boston Partners increased its holdings in shares of Tenet Healthcare by 15.7% in the fourth quarter. Boston Partners now owns 3,642,136 shares of the company’s stock valued at $723,804,000 after buying an additional 494,581 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of Tenet Healthcare by 20.3% during the 4th quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock valued at $448,419,000 after acquiring an additional 380,116 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after acquiring an additional 157,109 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of Tenet Healthcare during the fourth quarter worth $248,494,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.